The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

A study highlights significant body composition changes and increased cardiovascular risks in transgender men on testosterone ...

Research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to ...

Early menopausal hormone therapy neither benefits nor harms long-term cognition, offering reassurance but no protection ...

The battle against breast cancer has produced significant triumphs in recent years, with new and tailored treatments now ...

Growth hormone exerts direct and indirect effects ... further studies are needed to assess the potential role of this adjuvant therapy in heart failure patients.

"Ascendis Pharma submits sBLA for growth hormone deficiency therapy" was originally created and published by Pharmaceutical ...

Growth-hormone (GH) secretion is reduced in obesity, but studies of GH therapy in obese individuals have produced conflicting results. A meta-analysis of studies on the effects of recombinant ...

In January 2024, researchers in the U.K. published a study in the journal Nature Medicine proposing that several people who received cadaveric growth hormone between 1959 and 1989 as a treatment ...

Hormone therapy for prostate cancer has come a long way in the past few decades. Not so long ago, the only hormonal treatment for this disease was drastic: an orchiectomy, the surgical removal of ...